Vuélvete ilimitado con Magzter GOLD
Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo
Intentar ORO - Gratis
More and more organisations in India understand and have diversity, equity and inclusion as a key priority
Express Pharma
|June 2021
Lene Hylling Axelsson, Corporate Vice President, Global Business Services, Novo Nordisk shares details about the milestones and experiences in her career journey, evolution and progress of pharma Global Business Operations, challenges faced by the PHL industry during the pandemic, diversity, equity and inclusion in the workplace and more, in an interview with Ashwini Prakash, Managing Partner India, Asia Pacific Lead – Pharma, Healthcare, Life Sciences and Consumer products, Stanton Chase India
Lene Hylling Axelsson, Corporate Vice President, Global Business Services, Novo Nordisk
You are a global leader today; tell us about your career journey?
I have been working with the same company for 25 years and recently celebrated my 25th work anniversary at Novo Nordisk. Such a long time in a single organisation might sound boring to many, but at Novo Nordisk, I have worked in different functions including sales, marketing, finance, and production across different geographies - North and South Europe, the US, Japan and now in India where I am heading the Global Shared Services in India for the last two years. I feel 25 years have flown away quickly but I also feel that I got a lot of opportunities during my career. I never imagined I would be here for this long. Whenever I tried to explore opportunities outside Novo Nordisk, I have always come back with the feeling that the opportunities at Novo Nordisk are much more challenging and exciting. The company has since been on a wonderful journey in 25 years, expanding its services and reaching out to many more patients across the world. Today, we are among the top 10 pharma companies in the world. I feel my journey is closely linked with Novo Nordisk which itself has been very inspirational and interesting.
Ashwini Prakash, Managing Partner India, Asia Pacific Lead – Pharma, Healthcare, Life Sciences and Consumer products, Stanton Chase India
How are the pharma Global Business Operations (GBO) disrupting the Pharma, Healthcare and Lifesciences (PHL) industry?
Esta historia es de la edición June 2021 de Express Pharma.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Express Pharma
Express Pharma
Standardisation vs customisation in single-use systems for bioprocessing: What do biopharma companies need?
Priyabrata Pattnaik, CEO, Ami Polymer highlights the balance between standardisation and customisation in single - use systems in biopharma manufacturing
5 mins
May 2026
Express Pharma
Ensuring Pharma compliance with testo data measurement technology
Due to the crucial necessity and its direct impact on human health and welfare, Pharma is probably the most important and critical sector among others.
3 mins
May 2026
Express Pharma
China+1 moment for pharma: How India can convert opportunity into long-term contracts
Manish Jain, Director, Naprod Life Sciences explains how India must move beyond cost advantage to lead with reliability, quality, and transparency to reshape global pharma supply chains and position itself as a trusted, long-term partner
3 mins
May 2026
Express Pharma
Beyond scale: Rethinking new frontiers in building excellence
At the Injectable Innovations Conclave 2026, hosted by Express Pharma, industry leaders examined the trends, technologies and strategies shaping the next phase of injectable growth, reports
10 mins
May 2026
Express Pharma
Waters receives CE mark for BD BACTEC FXI Culture System under EU IVDR
Next-generation blood culture system records ~3-hour faster detection time and introduces automated blood volume measurement
2 mins
May 2026
Express Pharma
JNPC: Carrying forward a 20-year old legacy
Billed as India's first bulk drug, chemicals and allied manufacturing parks and one of the most successful public-private partnerships (PPP) in the pharma sector, the Jawaharlal Nehru Pharma City (JNPC), also known as Visakha Pharma City, was set up in February 2005 as a PPP initiative by the Govt of Andhra Pradesh (GoAP) through its nodal agency Andhra Pradesh Industrial Infrastructure Corporation (APIIC) with the Ramky Group on a Build-Own-Operate (BOO) basis for 20 years.
3 mins
May 2026
Express Pharma
Romaco's sustainable blister packaging line at interpack
At this year's interpack, the Romaco Group will present its sustainable Unity 600 high-speed blister packaging line, featuring – for the first time – the PF 75 stretch bander.
6 mins
May 2026
Express Pharma
Even drug-resistant cancer targets can be tackled with the right design strategy
Dr Bajarang Kumbhar, Assistant Professor, Sunandan Divatia School of Science, NMIMS Mumbai, explains how Al-driven computational biology is reshaping CAR-T therapy and highlights how these approaches help cut drug discovery timelines and improve targeted, personalised cancer treatment, in an interaction with Kalyani Sharma
7 mins
May 2026
Express Pharma
Navigating legal and regulatory landscape of GLP-1 drugs in India
GLP-1 drugs are drawing sharp regulatory and legal scrutiny, especially with generics entering post-patent expiry. They emphasise that navigating IP, compliance, and marketing rules is now critical for stakeholders
5 mins
May 2026
Express Pharma
From back office to brain trust: How life sciences GCCs are redefining leadership hiring in India
Sai Gandhi, Partner, Positive Moves points out that life sciences GCCs in India are moving from support roles to driving core innovation and global strategy. In turn, leadership hiring is shifting toward cross-functional, globally savvy leaders who can deliver enterprise-wide impact
4 mins
May 2026
Translate
Change font size